Association between the methylenetetrahydrofolate reductase C677T polymorphism and hepatocellular carcinoma risk: A meta-analysis

Diagnostic Pathology

Volumn 4, Issue 1, 2009, Pages

  Jin, Fei ^a   Qu, Li Shuai ^a   Shen, Xi Zhong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 72349100160     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-4-39     Document Type: Article

References (48)

1. Hepatocellular carcinoma pathogenesis: from genes to environment. PA Farazi RA DePinho, Nat Rev Cancer 2006 6 9 674 687 10.1038/nrc1934 16929323
2. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. M Munaka K Kohshi T Kawamoto S Takasawa N Nagata H Itoh S Oda T Katoh, J Cancer Res Clin Oncol 2003 129 6 355 360 10.1007/s00432-003-0439-5 12759747
3. UDP-glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers? I Stucker MA Loriot G N'Koutchou S Cenee L Bodin C Mulot M Gelu-Simeon L Pelletier JP Bronowicki F Degos P Beaune P Laurent-Puig D Hemon JC Trinchet G Pelletier, BMC Cancer 2007 7 214 10.1186/1471-2407-7-214 18021430
4. Are polymorphisms of N-acetyltransferase genes susceptible to primary liver cancer in Luoyang, China? XF Zhang JC Bian XY Zhang ZM Zhang F Jiang QM Wang QJ Wang YY Cao BM Tang, World J Gastroenterol 2005 11 10 1457 1462 15770721
5. Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients. S Ezzikouri AE El Feydi A Chafik R Afifi L El Kihal M Benazzouz M Hassar P Pineau S Benjelloun, Mutat Res 2008 649 1-2 1 6 18023606
6. Alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 genotypes, alcohol drinking and the risk of primary hepatocellular carcinoma in a Chinese population. J Ding S Li J Wu C Gao J Zhou H Cao PS Su Y Liu X Zhou J Chang, Asian Pac J Cancer Prev 2008 9 1 31 35 18439068
7. The structure and properties of methylenetetrahydrofolate reductase from Escherichia coli suggest how folate ameliorates human hyperhomocysteinemia. BD Guenther CA Sheppard P Tran R Rozen RG Matthews ML Ludwig, Nat Struct Biol 1999 6 4 359 365 10.1038/7594 10201405
8. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. P Frosst HJ Blom R Milos P Goyette CA Sheppard RG Matthews GJ Boers M den Heijer LA Kluijtmans LP van den Heuvel R Rozen, Nat Genet 1995 10 1 111 113 10.1038/ng0595-111 7647779
9. Predicting deleterious amino acid substitutions. PC Ng S Henikoff, Genome Res 2001 11 5 863 874 10.1101/gr.176601 11337480
10. Human non-synonymous SNPs: server and survey. V Ramensky P Bork S Sunyaev, Nucleic Acids Res 2002 30 17 3894 3900 10.1093/nar/gkf493 12202775
11. Identification and analysis of deleterious human SNPs. P Yue J Moult, J Mol Biol 2006 356 5 1263 1274 10.1016/j.jmb.2005.12.025 16412461
12. MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: A meta-analysis of 3511 cases and 2762 controls. JL Bai MH Zheng X Xia M Ter-Minassian YP Chen F Chen, Eur J Cancer 2009 45 8 1443 1449 10.1016/j.ejca.2009.01.020 19223177
13. Methylenetetrahydrofolate reductase (MTHFR) and breast cancer risk: a nested-case-control study and a pooled meta-analysis. T Langsenlehner W Renner B Yazdani-Biuki U Langsenlehner, Breast Cancer Res Treat 2008 107 3 459 460 10.1007/s10549-007-9564-1 17453338
14. The MTHFR C677T polymorphism and colorectal cancer: the multiethnic cohort study. L Le Marchand LR Wilkens LN Kolonel BE Henderson, Cancer Epidemiol Biomarkers Prev 2005 14 5 1198 1203 10.1158/1055-9965.EPI-04-0840 15894672 (Pubitemid 40656467)
15. Polymorphisms of 5,10-methylenetetralydrofolate reductase (MTHFR), fruit and vegetable intake, and the risk of stomach cancer. LN Mu W Cao ZF Zhang SZ Yu QW Jiang NC You QY Lu XF Zhou BG Ding J Chang CW Chen GR Wei L Cai, Biomarkers 2007 12 1 61 75 10.1080/13547500600945101 17438654
16. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study. MR Karagas S Park HH Nelson AS Andrew L Mott A Schned KT Kelsey, Int J Hyg Environ Health 2005 208 5 321 327 10.1016/j.ijheh.2005.04.005 16217917 (Pubitemid 41207424)
17. Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan. CX Yang K Matsuo H Ito M Shinoda S Hatooka K Hirose K Wakai T Saito T Suzuki T Maeda K Tajima, Carcinogenesis 2005 26 7 1285 1290 10.1093/carcin/bgi076 15790587
18. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. M Krajinovic S Lamothe D Labuda E Lemieux-Blanchard Y Theoret A Moghrabi D Sinnett, Blood 2004 103 1 252 257 10.1182/blood-2003-06-1794 12958073 (Pubitemid 38029946)
19. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption. C Fabris P Toniutto E Falleti E Fontanini A Cussigh D Bitetto E Fornasiere E Fumolo C Avellini R Minisini M Pirisi, Alcohol Clin Exp Res 2009 33 1 102 107 10.1111/j.1530-0277. 2008.00816.x 18945219
20. Methylenetetrahydrofolate reductase (MTHFR) and methionine synthase reductase (MTRR) gene polymorphisms as risk factors for hepatocellular carcinoma in a Korean population. SY Kwak UK Kim HJ Cho HK Lee HJ Kim NK Kim SG Hwang, Anticancer Res 2008 28 5A 2807 2811 19035314
21. MTHFR C677TT, PAI1 4G-4G, V Leiden Q506, and prothrombin G20210A in hepatocellular carcinoma with and without portal vein thrombosis. M D'Amico L Pasta P Sammarco, J Thromb Thrombolysis 2009 28 1 70 3 10.1007/s11239-008-0246-6 18618228
22. Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms and the risk of primary hepatocellular carcinoma (HCC) in a Chinese population. LN Mu W Cao ZF Zhang L Cai QW Jiang NC You BY Goldstein GR Wei CW Chen QY Lu XF Zhou BG Ding J Chang SZ Yu, Cancer Causes Control 2007 18 6 665 675 10.1007/s10552-007-9012-x 17503006
23. [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma]. ZZ Zhu WM Cong SF Liu ZH Xian WQ Wu, Zhonghua Gan Zang Bing Za Zhi 2006 14 3 196 198 16556414
24. The MTHFR 677C > T polymorphism is associated with an increased risk of hepatocellular carcinoma in patients with alcoholic cirrhosis. R Saffroy P Pham F Chiappini M Gross-Goupil L Castera D Azoulay A Barrier D Samuel B Debuire A Lemoine, Carcinogenesis 2004 25 8 1443 1448 10.1093/carcin/bgh147 15033905
25. Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma. JM Yuan SC Lu D Van Den Berg S Govindarajan ZQ Zhang JM Mato MC Yu, Hepatology 2007 46 3 749 758 10.1002/hep.21735 17659576
26. Hyperhomocysteinaemia in chronic liver diseases: role of disease stage, vitamin status and methylenetetrahydrofolate reductase genetics. P Ventura MC Rosa G Abbati S Marchini E Grandone P Vergura S Tremosini ML Zeneroli, Liver Int 2005 25 1 49 56 10.1111/j.1478-3231.2005.01042.x 15698398
27. HuGE Navigator. http://www.hugenavigator.net
28. A method for meta-analysis of molecular association studies. A Thakkinstian P McElduff C D'Este D Duffy J Attia, Stat Med 2005 24 9 1291 1306 10.1002/sim.2010 15568190
29. Quantitative synthesis in systematic reviews. J Lau JP Ioannidis CH Schmid, Ann Intern Med 1997 127 9 820 826 9382404
30. Heterogeneity testing in meta-analysis of genome searches. E Zintzaras JP Ioannidis, Genet Epidemiol 2005 28 2 123 137 10.1002/gepi.20048 15593093
31. Quantifying heterogeneity in a meta-analysis. JP Higgins SG Thompson, Stat Med 2002 21 11 1539 1558 10.1002/sim.1186 12111919
32. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. S Wacholder S Chanock M Garcia-Closas L El Ghormli N Rothman, J Natl Cancer Inst 2004 96 6 434 442 15026468
33. Power and sample size calculations. A review and computer program. WD Dupont WD Plummer Jr, Control Clin Trials 1990 11 2 116 128 10.1016/0197- 2456(90)90005-M 2161310
34. Power and sample size calculations for studies involving linear regression. WD Dupont WD Plummer Jr, Control Clin Trials 1998 19 6 589 601 10.1016/S0197-2456(98)00037-3 9875838
35. Estimating the population attributable risk for multiple risk factors using case-control data. P Bruzzi SB Green DP Byar LA Brinton C Schairer, Am J Epidemiol 1985 122 5 904 914 4050778
36. MTHFR C677TT, PAI1 4G-4G, V Leiden Q506, and prothrombin G20210A in hepatocellular carcinoma with and without portal vein thrombosis. M D'Amico L Pasta P Sammarco, J Thromb Thrombolysis 2009 28 1 70 73 10.1007/s11239-008-0246- 6 18618228
37. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. BC Blount MM Mack CM Wehr JT MacGregor RA Hiatt G Wang SN Wickramasinghe RB Everson BN Ames, Proc Natl Acad Sci USA 1997 94 7 3290 3295 10.1073/pnas.94.7.3290 9096386
38. 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C - T and 1298A - C mutations are associated with DNA hypomethylation. R Castro I Rivera P Ravasco ME Camilo C Jakobs HJ Blom IT de Almeida, J Med Genet 2004 41 6 454 458 10.1136/jmg.2003.017244 15173232
39. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. LL Stern JB Mason J Selhub SW Choi, Cancer Epidemiol Biomarkers Prev 2000 9 8 849 853 10952104
40. Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. SM Langevin D Lin K Matsuo CM Gao T Takezaki RZ Stolzenberg-Solomon M Vasavi Q Hasan E Taioli, Toxicol Lett 2009 184 2 73 80 10.1016/j.toxlet.2008.09.003 18840514
41. Polymorphisms of methylenetetrahydrofolate reductase and methionine synthase genes and bladder cancer risk: a case-control study with meta-analysis. M Wang H Zhu G Fu Z Zhang Q Lu S Wang, Clin Exp Med 2009 9 1 9 19 10.1007/s10238-008-0013-1 18815869
42. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. S Boccia P Boffetta P Brennan G Ricciardi F Gianfagna K Matsuo CM van Duijn RJ Hung, Cancer Lett 2009 273 1 55 61 10.1016/j.canlet.2008.07.026 18789576
43. Meta- and pooled analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer risk: a huge-GSEC review. S Boccia R Hung G Ricciardi F Gianfagna MP Ebert JY Fang CM Gao T Gotze F Graziano M Lacasana-Navarro D Lin L Lopez-Carrillo YL Qiao H Shen R Stolzenberg-Solomon T Takezaki YR Weng FF Zhang CM van Duijn P Boffetta E Taioli, Am J Epidemiol 2008 167 5 505 516 10.1093/aje/kwm344 18162478
44. One-carbon metabolism gene polymorphisms and risk of non-Hodgkin lymphoma in Australia. KM Lee Q Lan A Kricker MP Purdue AE Grulich CM Vajdic J Turner D Whitby D Kang S Chanock N Rothman BK Armstrong, Hum Genet 2007 122 5 525 533 10.1007/s00439-007-0431-2 17891500 (Pubitemid 350148964)
45. Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. J Lissowska MM Gaudet LA Brinton SJ Chanock B Peplonska R Welch W Zatonski N Szeszenia-Dabrowska S Park M Sherman M Garcia-Closas, Int J Cancer 2007 120 12 2696 2703 10.1002/ijc.22604 17311260
46. MTHFR C677T and colorectal cancer risk: A meta-analysis of 25 populations. RA Hubner RS Houlston, Int J Cancer 2007 120 5 1027 1035 10.1002/ijc.22440 17131337
47. A meta-analysis of genotypes and haplotypes of methylenetetrahydrofolate reductase gene polymorphisms in acute lymphoblastic leukemia. E Zintzaras T Koufakis PD Ziakas P Rodopoulou S Giannouli M Voulgarelis, Eur J Epidemiol 2006 21 7 501 510 10.1007/s10654-006-9027-8 16897583
48. The role of MTHFR gene in multiple myeloma. E Zintzaras S Giannouli P Rodopoulou M Voulgarelis, J Hum Genet 2008 53 6 499 507 10.1007/s10038-008-0277- z 18350248